Multiple biotech stocks are seeing gains on Monday, on the heels of Valeant Pharmaceutical’s VRX Acquisition of Salix Pharmaceuticals SLXP.
Biocept Inc. BIOC +62% - Announced positive findings from OncoCEE-BR Study.
Rigel Pharmaceuticals RIGL +36% - Reported research collaboration with Bristol-Myers Squibb.
Celldex Therapeutics CLDX +19% - Received breakthrough designation from FDA for Rintega.
Valeant Pharmaceutical’s VRX +14% - Acquired Salix Pharma for $158 per share.
Genetic Technologies Limited ADR GENE +13.5%
ZIOPHARM Oncology Inc. ZIOP +10%
Stemline Therapeutics STML +8%
Pharmacyclics Inc. PCYC +8%
Kite Pharma KITE +5%
Idera Pharmaceuticals IDRA +5%
Agenus Inc. AGEN +6%
NASDAQ Biotechnology Index ETF IBB +0.26%
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.